Celalettin Ustun to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Celalettin Ustun has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.340
-
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leuk Lymphoma. 2020 12; 61(12):2811-2820.
Score: 0.180
-
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv. 2018 11 13; 2(21):2922-2936.
Score: 0.160